Follow Us

Terms of Use Privacy Policy

FDA Approves Drug to Prevent Migraines

FDA Approves Drug to Prevent Migraines Aimovig was approved on Thursday, become the first medicine of its kind — a once a month injection used to block a key molecule that starts migraines. In clinical trials, the FDA said most people experienced one less migraine a month after taking Aimovig. Research on migraines goes back to the 1980’s, in which it was found that sufferers had high levels of a protein called CGRP in their blood. Migraines can become debilitating to the point they create nausea, visual disturbances and light sensitivity. The drugmaker, Amgen, has set the list price at $6,900 a year.

Source: Inform News

Top Trending Videos